Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cancer Research|September 30, 2010
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic miceMarco De Andrea, Massimo Rittà, Manuela M Landini, et al.
Journal of Proteomics|November 5, 2018
Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel diseaseMarcello Manfredi, Eleonora Conte, Elettra Barberis, et al.
The Journal of Investigative Dermatology|June 10, 2017
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell ExpansionSimone Lanfredini, Carlotta Olivero, Cinzia Borgogna, et al.
Journal of the American Academy of Dermatology|March 12, 2014
α- and β-papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesionsManuela M Landini, Cinzia Borgogna, Alberto Peretti, et al.
Frontiers in Cellular and Infection Microbiology|March 26, 2024
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancerCamilla Albano, Matteo Biolatti, Jasenka Mazibrada, et al.
The Journal of Investigative Dermatology|October 17, 2008
High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformisValentina Dell'Oste, Barbara Azzimonti, Marco De Andrea, et al.
Communications Biology|March 8, 2024
Human cytomegalovirus infection triggers a paracrine senescence loop in renal epithelial cellsStefano Raviola, Gloria Griffante, Andrea Iannucci, et al.
Viruses|November 27, 2021
Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort StudyGloria Griffante, Shikha Chandel, Daniela Ferrante, et al.
Communications Biology|June 1, 2026
IFI16 restricts SARS-CoV-2 replication by disrupting nucleocapsid-driven phase separationIlaria Cislaghi, Sarah Turati, Dalila Vicario, et al.
Blood Cancer Journal|January 19, 2022
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patientsCinzia Borgogna, Riccardo Bruna, Gloria Griffante, et al.
Pageof 9